Your browser doesn't support javascript.
loading
The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era.
Kobayashi, T; Kuroda, J; Yokota, I; Tanba, K; Fujino, T; Kuwahara, S; Isa, R; Yamaguchi, J; Kawata, E; Akaogi, T; Uchiyama, H; Kaneko, H; Uoshima, N; Kobayashi, Y; Teramukai, S; Taniwaki, M.
Afiliación
  • Kobayashi T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Yokota I; Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Tanba K; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Fujino T; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Kuwahara S; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Isa R; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Yamaguchi J; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Kawata E; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Akaogi T; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Uchiyama H; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Kaneko H; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Kobayashi Y; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Teramukai S; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan.
  • Taniwaki M; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
Blood Cancer J ; 6: e383, 2016 Jan 15.
Article en En | MEDLINE | ID: mdl-26771809

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2016 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2016 Tipo del documento: Article País de afiliación: Japón